Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING INC GLW
4.47%
SYNCHRONOSS SNCR
4.23%
Zacks ZACKS.COM
PROFIT from the PROS

Tactics that Work in Good Markets and Bad
 
--

Dear Subscriber,

This is going to be another busy week.

The results from the bank stress test should be released on Thursday. On Friday, we will see the April employment numbers.

Plus, the earnings reports are expected - about 850. Cisco Systems (CSCO), Kraft Foods (KFT) and Walt Disney (DIS) are a few scheduled to be released. Find out who could surprise in Earnings Preview.

Also, with the swine flu spreading, Health and Human Services (HHS) Secretary Kathleen Sebelius is looking to restock the government's supply of Tamiflu. This could be good news for Gilead (GILD) as Jason Napodano explains in our Analyst blog.

Wishing you prosperity,
Charles Rotblut, CFA
Senior Market Analyst & Editor,
Profit From the Pros

 

 

Today's Top Stories: Monday- May 04, 2009

ZACKS RANK BUY STOCKS

  • Aggressive Growth - HQ Sustainable Maritime Industries, Inc. (HQS) current estimates for full-year 2009 are now averaging $1.02, which would be a 30% growth. The consensus for 2010 is $1.42, which is another 38% growth.
    Read More...
     
  • Growth & Income - Corning Inc. (GLW) recently declared a quarterly dividend of 5 cents per share, noting that it is payable June 30 to holders of record on June 1. GLW offers an industry-leading yield of 1.4%. Read More...
     
  • Momentum - Buckle, Inc. (BKE) shares are seeing robust momentum on higher March sales and bullish analyst estimates. Current full-year forecasts of $2.53 per share are above last month’s $2.46. The most accurate estimate is more bullish at $2.56. Read More...
     
  • Value - Watson Pharmaceuticals, Inc. (WPI) revenue rose 6% to a record $667.4 million. The quarter was led by sales of generic products which rose 15% to $395.2 million over the year ago period. Watson is trading at 12.9x forward earnings. Read More...
     

Learn how to profit from our exclusive Zacks Rank stock-ranking system with free resources. Read More...


Sponsor


ZACKS MUTUAL FUND RANK
  • Best of Funds: Top Health Equity Funds
    Improve the health of your portfolio with Morgan Stanley Health Sciences A (HCRAX), Fidelity Advisor Health Care A (FACDX) and Kinetics Medical Adv A (KRXAX). Read More...

The new Zacks Mutual Fund Rank is free until June 1. See all the great mutual fund resources.

BEST OF ZACKS EQUITY RESEARCH

 


INVESTMENT IDEAS: Fighting the Market: A Losing Battle

Cash in on the recent rally using the Zacks Rank. Stocks highlighted include: Steven Madden Ltd (SHOO), Netease.com (NTES), and The Pantry Inc (PTRY). Read More...

PERSONAL FINANCE: provided by Kiplinger.com

EDUCATION: Aggressive Growth

Stocks “Neglected” By Analysts Read More...

 

PeopleAndPicks.com:

VIP "EyePhone" is spotting profit with BUY calls in (AMX), (BRY), (CPX) and (ENP). Read More...

NEW ZACKS VIDEOS:

FACEBOOK

Visit the Zacks.com Facebook page and get the latest insight on stocks and the market:
Zacks On Facebook

TWITTER

Get the Zacks.com newsfeed delivered straight to your Twitter account:
Zacks On Twitter

 

OTHER ZACKS RESOURCES:

 

Manage your Profit from the Pros subscription:

REFER-A-FRIEND

If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. THANKS!
Refer a Friend

Regards and Happy Investing,

Charles Rotblut, CFA
Senior Market Analyst
Zacks.com

p.s. What is the mission for Zacks Profit from the Pros? To find out how we will help you become a more successful investor, click here.

Visit /performance for information about the performance numbers displayed in this newsletter.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

To contact us by mail:

Zacks Investment Research
Attn: Profit from the Pros
111 N. Canal St., Suite 1101
Chicago, IL 60606

To unsubscribe from receiving "Zacks.com Profit from the Pros"
e-mail newsletter, Click here....

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.